4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001263136-26-000018
CFO, EVP & TREASURER sold 11,000 shares at $29.99 ($329,890)
- CFO, EVP & TREASURER acquired 11,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
PETERS WILLIAM J · CFO, EVP & TREASURER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +11,000 | $17.99 | $197,890 | 178,076 | D |
| 2026-11-16 | Sale : show line 2 in the form 10b5-1 | −11,000 | $29.99 | $329,890 | 167,076 | D |
| Open-market sales · 11,000 sh · avg $29.99 · $329,890 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2026-11-16 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) | −11,000 | $17.99 | 2031-03-17 | 11,000 | 56,833 | D |
Loading xslF345X06/form4-11182026_091142.xml…